March 11: The Week in Cancer News
FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.
Progress Against Cancer
FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...
Study finds lower rates of screening-related breast cancer overdiagnosis and other cancer research news of the week.
Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.
Millions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.
The COVID-19 pandemic has taken a devastating toll, with 5.8 million deaths worldwide, including nearly 1 million in the...
CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...